March 14, 2013
Welwyn Garden City, UK – Cresset, innovative provider of chemistry software and services, announces a new release of the popular XedTools package, including the next generation of the popular XED force field. The XedTools package contains command line utilities for studying molecular interactions using the XED molecular mechanics force field. This release brings an update [...]
METTLER TOLEDO and Thermo Fisher Scientific Introduce Combined Titration and Ion Chromatography
March 14, 2013
Schwerzenbach, Switzerland – METTLER TOLEDO, a world leader in precision analytical instrumentation, and Thermo Fisher Scientific Inc., a world leader in serving science, have combined their knowledge and instruments to provide multiparameter water testing. The new titration and IC (ion chromatography) system offers complete automation for testing properties and ions in drinking, ground, surface and [...]
March 14, 2013
Granada and Madrid, Spain and Madison, WI, U.S., – Integromics®, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces that it has entered into a consortium for the research on new methods to process quickly and efficiently the large sets of data that are produced in [...]
Illumina Announces Outcome of Its Patent Litigation Against Syntrix Biosystems, Inc.
March 14, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that a federal jury in Tacoma, Washington found that Illumina's BeadChip array product infringed U.S. Patent No.6,951, 682, asserted by Syntrix Biosystems, Inc. The federal jury ordered Illumina to pay approximately $96 million in damages to Syntrix based on a royalty rate of six percent for BeadChip [...]
March 14, 2013
WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has won a contract valued at approximately $585,000 for the sale of its Quantum Sniffer™ QS-H150 explosives trace detectors to a U.S. Government agency. "Implant Sciences' products are capable of [...]
Eurofins MWG Operon and Queen Mary, University Of London commence genome sequencing analysis of Ash
March 14, 2013
Ebersberg, Germany, - Eurofins MWG Operon and School of Biological and Chemical Sciences, Queen Mary, University of London, have recently signed a cooperation agreement on the genome sequencing analysis of Ash (Fraxinus excelsior). The major aim of this project is to increase our understanding of the wide spreading fungal tree disease – ash dieback (Hymenoscyphus [...]
Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
March 14, 2013
Genomics data management leader Annai Systems is the architect of the Cancer Genomics Hub (CGHub), a repository for genomic data from major research initiatives of the National Cancer Institute. The company has worked closely with the research community to optimize the accessibility and usability of this unique collection of data on tumor genomes. “Researchers told [...]
Airgas to Unveil Award-Winning New Products at PITTCON 2013
March 13, 2013
RADNOR, PA - Airgas, Inc. (NYSE: ARG), one of the largest U.S. suppliers of specialty gases and equipment, will unveil three new products designed to maximize efficiency and purity in gas chromatography at the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (PITTCON) in Philadelphia, March 18th - 21st. Two of the products - Airgas [...]
Transgenomic Secures $8.0 Million Credit Facility
March 13, 2013
Omaha, Neb. - Transgenomic, Inc. (OTC/BB: TBIO) today announced that it has secured an $8.0 million term and revolving credit facility from Third Security Senior Staff 2008 LLC, Third Security Staff 2010 LLC, and Third Security Incentive 2010 LLC (collectively, the “Third Security Investors”), which are entities affiliated with Third Security, LLC, a leading life [...]
March 13, 2013
WHITEHOUSE STATION, N.J. & AUSTIN, Texas -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Luminex Corporation (NASDAQ:LMNX) have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel [...]
